Evidence map›Paper›PMID 28495973›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression.

Amber L LaCrosse, Sinead M O'Donovan, Marian T Sepulveda-Orengo, Robert E McCullumsmith, Kathryn J Reissner, Marek Schwendt, Lori A Knackstedt

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. MC-100093, a NovelThe Journal of pharmacology and experimental therapeutics · 2021
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Amber L LaCrossePsychology Department, University of Florida, Gainesville, Florida 32611.
Sinead M O'DonovanDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio 45267.
Marian T Sepulveda-OrengoDepartment of Psychology and Neuroscience, University of North Carolina, Chapel Hill, North Carolina 27599, and.ORCID 0000-0002-8970-9328
Robert E McCullumsmithDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio 45267.
Kathryn J ReissnerDepartment of Psychology and Neuroscience, University of North Carolina, Chapel Hill, North Carolina 27599, and.
Marek SchwendtPsychology Department, University of Florida, Gainesville, Florida 32611.
Lori A KnackstedtPsychology Department, University of Florida, Gainesville, Florida 32611, knack@ufl.edu.
University of Florida · USUniversity of Cincinnati · USUniversity of North Carolina at Chapel Hill · US

Funding

GLT-1 Enhancers as Drug Candidates for Treating Cocaine AddictionR01DA037270 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ABOU-GHARBIA, MAGID, ROTHSTEIN, JEFFREY D · 2014 to 2018
$2.0M
Astrocyte-mediated mechanisms of cocaine seekingR01DA041455 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI REISSNER, KATHRYN JOANNA · 2016 to 2020
$1.7M
Defects of subcellular glutamate transporter localization in schizophreniaR01MH094445 · NIMH · UNIVERSITY OF CINCINNATI · PI MCCULLUMSMITH, ROBERT E · 2011 to 2015
$1.7M
Glutamate Transporters and Cocaine SeekingR01DA033436 · NIDA · UNIVERSITY OF FLORIDA · PI KNACKSTEDT, LORI A · 2012 to 2016
$1.3M
Proteomic analysis of the postsynaptic density-95 interactome in schizophreniaR21MH107916 · NIMH · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI MCCULLUMSMITH, ROBERT E · 2016 to 2017
$434k
NIDA NIH HHS R01 DA033436NIDA NIH HHS R01 DA037270NIDA NIH HHS R01 DA041455NIMH NIH HHS R01 MH094445NIMH NIH HHS R21 MH107916
6 · The paper itself

Abstract

Long-term treatment with ceftriaxone attenuates the reinstatement of cocaine seeking while increasing the function of the glutamate transporter 1 (GLT-1) and system xC- (Sxc) in the nucleus accumbens core (NAc). Sxc contributes the majority of nonsynaptic extracellular glutamate in the NAc, while GLT-1 is responsible for the majority of glutamate uptake. Here we used antisense to decrease the expression of GLT-1 and xCT (a catalytic subunit of Sxc) to determine the relative importance of both proteins in mediating the ability of ceftriaxone to prevent cue-induced reinstatement of cocaine seeking and normalize glutamatergic proteins in the NAc of rats. Intra-NAc xCT knockdown prevented ceftriaxone from attenuating reinstatement and from upregulating GLT-1 and resulted in increased surface expression of AMPA receptor subunits GluA1 and GluA2. Intra-NAc GLT-1 knockdown also prevented ceftriaxone from attenuating reinstatement and from upregulating xCT expression, without affecting GluA1 and GluA2 expression. In the absence of cocaine or ceftriaxone treatment, xCT knockdown in the NAc increased the expression of both GluA1 and GluA2 without affecting GLT-1 expression while GLT-1 knockdown had no effect. PCR and immunoprecipitation of GLT-1 revealed that ceftriaxone does not upregulate GLT-1 and xCT through a transcriptional mechanism, and their coregulation by ceftriaxone is not mediated by physical interaction. These data support important and distinct roles for xCT and GLT-1 in the actions of ceftriaxone and add to a body of literature finding evidence for coregulation of these transporters. Our results also point to xCT expression and subsequent basal glutamate levels as being a key mediator of AMPA receptor expression in the NAc.

Indexed as

Amino Acid Transport Systems, AcidicAmino Acid Transport System y+AnimalsCeftriaxoneCocaine-Related DisordersDrug-Seeking BehaviorExcitatory Amino Acid Transporter 2MaleNucleus AccumbensRatsRats, Sprague-DawleyReceptors, AMPARecurrenceTreatment OutcomeUp-RegulationAmino Acid Transport Systems, AcidicAmino Acid Transport System y+CeftriaxoneExcitatory Amino Acid Transporter 2Receptors, AMPASlc1a2 protein, ratSlc7a11 protein, ratglutamateglutamate transportersmicrodialysisnucleus accumbensrelapse

Identifiers

PMID28495973
PMCPMC5473201
OpenAlexW2614010581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.